Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

QR Code

Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

Abstract Background Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. Met...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Qingguo Li, Huizhen Sun, Dakui Luo, Lu Gan, Shaobo Mo, Weixing Dai, Lei Liang, Yufei Yang, Midie Xu, Jing Li, Peiyong Zheng, Xinxiang Li, Yan Li, Ziliang Wang
Format:	article
Langue:	EN
Publié:	BMC 2021
Sujets:	Lnc-RP11-536 K7.3 Organoid Oxaliplatin Colon cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/8081b82ccf514fbfbfb89fb2a0cf39cc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Descripción y análisis de la Ley sobre Violencia Escolar (N°20.536): dos paradigmas antagónicos
par: Magendzo K,Abraham, et autres
Publié: (2013)

Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
par: Li Y, et autres
Publié: (2020)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
par: Dan Lin, et autres
Publié: (2021)

Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
par: Hélène Bellio, et autres
Publié: (2021)

A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier
par: Ye H, et autres
Publié: (2021)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
par: Nicolas Kerckhove, et autres
Publié: (2021)

Teoría sociológica clásica /
par: Ritzer, George
Publié: (1993)

Teoría sociológica contemporánea /
par: Ritzer, George
Publié: (1996)

Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer
par: Pangeni R, et autres
Publié: (2020)

Antioxidant support to ameliorate the oxaliplatin-dependent microglial alteration: morphological and molecular study
par: Jacopo J.V. Branca, et autres
Publié: (2021)

lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
par: Cai M, et autres
Publié: (2021)

Prediction of esophagogastric varices associated with oxaliplatin administration
par: Yosuke Satta, et autres
Publié: (2021)

DEVELOPMENT AND VALIDATION OF RP- HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TRAMADOL HYDROCHLORIDE AND DICYCLOMINE IN BULK AND PHARMACEUTICAL FORMULATION
par: DONDA,SHAILESH T, et autres
Publié: (2016)

SIMULTANEOUS DETERMINATION OF ENALAPRIL AND STATIN'S IN PHARMACEUTICAL FORMULATIONS BY RP-HPLC
par: SULTANA,NAJMA, et autres
Publié: (2011)

Phytic acid potentiates oxaliplatin effects in colorectal cancer induced by 1,2-DMH: the role of miR-224 and miR-200a
par: Tarek M. Okda, et autres
Publié: (2021)

SIMULTANEOUS ESTIMATION OF ESOMEPRAZOLE AND LEVOSULPIRIDE IN BULK AND IN CAPSULE FORMULATION BY RP-HPLC
par: JAIN,RAKESHR, et autres
Publié: (2013)

Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
par: Aerziguli Aierken, et autres
Publié: (2021)

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF TRIFLUSAL IN BULK AND IN CAPSULE FORMULATION
par: PATIL,VIJAYK, et autres
Publié: (2012)

SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE SODIUM PHOSPHATE IN BULK AND IN OPHTHALMIC SOLUTION BY RP- HPLC
par: DHUMAL,D. M, et autres
Publié: (2012)

SIMULTANEOUS DETERMINATION OF LEVODROPROPIZINE, METHYLPARABEN, AND PROPYLPARABEN IN ORAL CO-FORMULATED SYRUP BY RP-HPLC METHOD
par: WESHAHY,SOHEIR ABD EL-FATAH, et autres
Publié: (2015)

STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION
par: MUSTAFA,GULAM, et autres
Publié: (2010)

Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation
par: Pangeni R, et autres
Publié: (2016)

SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC
par: SULTANA,NAJMA, et autres
Publié: (2010)

VALIDATED RP-HPLC METHOD FOR QUANTITATION OF GLIQUIDONE IN PHARMACEUTICAL FORMULATION AND HUMAN SERUM
par: ARAYNE,M. SAEED, et autres
Publié: (2010)

Current Status of Breast Organoid Models
par: Srivarshini Cherukupalli Mohan, et autres
Publié: (2021)

The p53 family member p73 in the regulation of cell stress response
par: Julian M. Rozenberg, et autres
Publié: (2021)

Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
par: Fan Chen, et autres
Publié: (2021)

BOX-BEHNKEN SUPPORTED DEVELOPMENT AND VALIDATION OF ROBUST RP-HPLC METHOD: AN APPLICATION IN ESTIMATION OF PRAVASTATIN IN BULK AND PHARMACEUTICAL DOSAGE FORM
par: AHMAD,AJAZ, et autres
Publié: (2016)

CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
par: Zhao-wei Gao, et autres
Publié: (2021)

Topical Delivery of Four Neuroprotective Ingredients by Ethosome-Gel: Synergistic Combination for Treatment of Oxaliplatin-Induced Peripheral Neuropathy
par: Lin HM, et autres
Publié: (2020)

Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
par: Hannah K. Hopkins, et autres
Publié: (2021)

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
par: Ping Chen, et autres
Publié: (2021)

SOX9: Advances in Gynecological Malignancies
par: Huan Chen, et autres
Publié: (2021)

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes
par: Mikkel G. Terp, et autres
Publié: (2021)

IN VITRO STUDIES OF INTERACTION BETWEEN METFORMIN AND NSAIDS (NON STEROIDAL ANTI-INFLAMATORY DRUGS) USING SPECTROPHOTOMETRY AND RP-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
par: ARAYNE,M. SAEED, et autres
Publié: (2010)

Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy
par: Emre Küçükköse, et autres
Publié: (2021)

New stability indicating RP-HPLC-PDA method for determination of mifepristone in bulk and tablet formulation
par: Mohammad Mojeeb Gulzar Khan, et autres
Publié: (2021)

DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF DICYCLOMINE HYDROCHLORIDE AND FAMOTIDINE IN BULK AND TABLETS
par: DONDA,SHAILESH T, et autres
Publié: (2014)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
par: Hefei Li, et autres
Publié: (2021)

Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene–platinum(II) conjugate
par: Avaji PG, et autres
Publié: (2016)